面对市场激烈竞争与2026年销售下滑预期,诺和诺德CEO坦言明星减肥药Wegovy降价对财务造成“痛苦”影响,但旨在以价换量。为稳定信心,公司宣布启动最高38亿丹麦克朗的股票回购,并计划派发股息,同时寄望于新款口服Wegovy片剂能推动未来增长。丹麦制药巨头诺和诺德正面临近十年来最严峻的业绩挑战,公司预计2026年销售额将显著下滑,市场竞争正日趋激烈。2月4日,公司CEO Mike ...
Source Link面对市场激烈竞争与2026年销售下滑预期,诺和诺德CEO坦言明星减肥药Wegovy降价对财务造成“痛苦”影响,但旨在以价换量。为稳定信心,公司宣布启动最高38亿丹麦克朗的股票回购,并计划派发股息,同时寄望于新款口服Wegovy片剂能推动未来增长。丹麦制药巨头诺和诺德正面临近十年来最严峻的业绩挑战,公司预计2026年销售额将显著下滑,市场竞争正日趋激烈。2月4日,公司CEO Mike ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.